An increase in the expression of ACE2, a tissue-protective mediator during lung damage, was found to be associated with interferon signaling in airway epithelial cells, and SARS-CoV-2 could exploit interferon-mediated stimulation of ACE2 to augment infection (Ziegler et al., 2020). The gene discussed is ACE2; the disease is infection.